Pregnant woman
(© Alexey05 | Dreamstime Stock Photos & Stock Free Images)

U.S. health regulators have approved a drug to treat morning sickness that was withdrawn from the market 30 years ago amid claims, since debunked, that it caused birth defects.

The drug, Diclegis, made by Duchesnay Inc, a private Canadian company, is a generic version of a product that was initially approved in the United States under the name Bendectin in 1956. It was withdrawn in 1983 following a slew of lawsuits from mothers claiming their children had been harmed by it.

The U.S. Food and Drug Administration did not prompt Bendectin’s manufacturer, Merrell Dow, to withdraw the product, and in fact the agency confirmed, in response to citizen petitions, that it had not been withdrawn because it was ineffective or posed a danger. It was withdrawn simply because the company could not afford to defend itself in court.

Like Bendectin, Diclegis consists of two main ingredients: doxylamine succinate, which is contained in several over-the-counter antihistamines; and pyroxidine hydrochloride, also known as vitamin B6. Diclectin comes in the form of a single pill and will be available only with a prescription.

Bringing the drug back to the market represents a bold move for the FDA, whose defining decision not to approve thalidomide, a sedative that was launched in Europe in 1957 and widely used to treat morning sickness before its link with birth defects was discovered, solidified the agency’s legitimacy and reputation as a safety watchdog.

Morning sickness affects a large portion of pregnant women. In most cases it can be managed through dietary measures such as snacking throughout the day and drinking ginger ale. But in rare cases, it is so severe that the woman requires hospitalization and treatment with intraveneous fluids.

(Additional reporting by Bill Berkrot in New York; Editing by Bernard Orr)

© 2013 Thomson Reuters. All rights reserved.

Draw closer to God. Experience the presence of the Holy Spirit every month as you read Charisma magazine. Sign up now to get Charisma for as low as $1 per issue.

Get to know the Holy Spirit and how to interact with Him on a daily basis. Learn to enter God's presence and hear His voice clearly for yourself! Go deeper in your faith with Life in the Spirit and change your life and destiny. Are you ready to start your journey?

Did you enjoy this health article? Click here to receive new health articles by email.

Your Turn

Comment Guidelines
View/Add Comments
Use Desktop Layout
Charisma Magazine — Empowering believers for life in the Spirit